Brevan Howard Capital Management LP Harrow Health, Inc. Transaction History
Brevan Howard Capital Management LP
- $9.23 Billion
- Q1 2025
A detailed history of Brevan Howard Capital Management LP transactions in Harrow Health, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 21,009 shares of HROW stock, worth $731,743. This represents 0.01% of its overall portfolio holdings.
Number of Shares
21,009
Previous 8,642
143.1%
Holding current value
$731,743
Previous $289,000
93.08%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding HROW
# of Institutions
187Shares Held
22.1MCall Options Held
330KPut Options Held
670K-
Opaleye Management Inc. Boston, MA3.96MShares$138 Million28.93% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$74.8 Million0.0% of portfolio
-
Private Capital Management, LLC Naples, FL1.89MShares$65.9 Million6.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$65.1 Million0.0% of portfolio
-
Braidwell LP Stamford, CT957KShares$33.3 Million1.56% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $943M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...